Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Tree

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 22, 2019
Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown UnknownsA C Tree
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 28, 2020
Yesterday's News is Today's Fish and Chip PaperA C Tree
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 13, 2019
Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate CancerA C Tree, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 16, 2018
Magnetic Resonance-guided Radiotherapy - Can We Justify More Expensive Technology?A C Tree, R Huddart, A Choudhury
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2015
Stereotactic body radiotherapy for prostate cancerD R Henderson, A C Tree, N J van As
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2019
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?P H Patel, D Palma, F McDonald, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 1, 2022
PEARLS: Is Our Use of Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography Meaningful for Our Patients?J R Murray, P Sankey, A C Tree, et al.
Radiography (London, England : 1995)|October 8, 2018
National survey of fiducial marker insertion for prostate image guided radiotherapyS E Alexander, J Kinsella, H A McNair, et al.
Clinical and Translational Radiation Oncology|March 20, 2023
GI factors, potential to predict prostate motion during radiotherapy; a scoping reviewS E Alexander, U Oelfke, H A McNair, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 18, 2014
Is biochemical relapse-free survival after profoundly hypofractionated radiotherapy consistent with current radiobiological models?A C Tree, V S Khoo, N J van As, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 22, 2019
Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown UnknownsA C Tree
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 28, 2020
Yesterday's News is Today's Fish and Chip PaperA C Tree
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 13, 2019
Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate CancerA C Tree, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 16, 2018
Magnetic Resonance-guided Radiotherapy - Can We Justify More Expensive Technology?A C Tree, R Huddart, A Choudhury
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2015
Stereotactic body radiotherapy for prostate cancerD R Henderson, A C Tree, N J van As
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2019
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?P H Patel, D Palma, F McDonald, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 1, 2022
PEARLS: Is Our Use of Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography Meaningful for Our Patients?J R Murray, P Sankey, A C Tree, et al.
Radiography (London, England : 1995)|October 8, 2018
National survey of fiducial marker insertion for prostate image guided radiotherapyS E Alexander, J Kinsella, H A McNair, et al.
Clinical and Translational Radiation Oncology|March 20, 2023
GI factors, potential to predict prostate motion during radiotherapy; a scoping reviewS E Alexander, U Oelfke, H A McNair, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 18, 2014
Is biochemical relapse-free survival after profoundly hypofractionated radiotherapy consistent with current radiobiological models?A C Tree, V S Khoo, N J van As, et al.
Pageof 3